Are the indications for administering ticagrelor and clopidogrel in patients with acute coronary syndrome different? Is the medical, insurance, or socioeconomic profile a consideration when choosing one over the other?
Year: 2026
Type: article
Abstract: Both ticagrelor and clopidogrel are indicated for ACS but ticagrelor is preferred for initial treatment due to superior cardiovascular outcomes. Considerations such as genetic profiles, contraindications, and bleeding risks play significant roles in the clinical decision between these agents.
Author: Tripdatabase
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7224413530